Last reviewed · How we verify
Naproxen Test
At a glance
| Generic name | Naproxen Test |
|---|---|
| Sponsor | Iroko Pharmaceuticals, LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) (PHASE1, PHASE2)
- PK,PD and DDI of Epaminurad and Naproxen in Healthy Volunteers (PHASE1)
- Pharmacogenetic-guided Choice of Post-surgery Analgesics (NA)
- A Study to Learn About Whether BAYH006689 Causes Skin Irritation When Applied as a Topical Gel in Healthy Participants (PHASE1)
- A Study to Learn About Whether BAY H006689 Causes an Allergic Reaction When Applied as a Topical Gel in Healthy Participants (PHASE1)
- Ibuprofen Inhibits Human Sweet Taste (NA)
- Dexmedetomine as Adjuvant for Spinal Anesthesia in Elective Cesarian Sections : a Pilot Study (PHASE3)
- Study of Sumatriptan Naproxen Sodium Succinate Tablets for the Treatment of Acute Migraine Attacks (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Naproxen Test CI brief — competitive landscape report
- Naproxen Test updates RSS · CI watch RSS
- Iroko Pharmaceuticals, LLC portfolio CI